Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

FREE BLOG Ethical practice in private healthcare investment

The healthcare sector has seen consistent global growth over the past decade, positioning itself as an increasingly attractive destination for private capital investment. But while private capital has been flooding into healthcare, it has raised some difficult questions. Can you really put patients first while chasing profits? And does private investment actually improve care, or […]
August 14, 2025

Bupa’s elderly care revenues surge

British multinational health insurer Bupa published their half year financial report last week, showing strong profits from elderly care performance. 
August 14, 2025

Assura shareholders give final approval to PHP takeover

UK healthcare real estate investor Assura has voted to accept a bid from Primary Health Properties (PHP), the only other UK REIT with a significant primary care portfolio. The decision brings an end to a takeover contest with US private equity firm KKR.
August 13, 2025

FREE BLOG How to keep your customers for the long-term

“How should suppliers work with their customers to ensure they can continue to afford their products and services in the long term?” That was the question posed to me last week by a group of healthcare procurement experts. We were sparring back and forth over topics to include in the agenda for HBI 2026 next March.
August 7, 2025

French pharmaceutical company Servier in “exclusive negotiations” to sell Biogaran to UK’s BC Partners

With France facing persistent medicine shortages and heightened political focus on healthcare sovereignty, the generic pharmaceuticals sector is drawing increased attention from private investors and policymakers alike. Growing interest in maintaining domestic production and securing supply chains has positioned French generics as both a strategic asset and a market opportunity.
August 7, 2025

From 0 to 250%: EU pharma and Trump’s tariffs

Last month, HBI covered how EU tariff negotiations would affect pharma prices. At that time, Donald Trump had been threatening a 50% tariff on all EU imports and a 200% tariff on pharmaceutical imports, creating much uncertainty around the final state of the trade deal. On Tuesday, however, Trump told CNBC that while the tariffs on pharmaceuticals may be “small” initially, in a year's time they will be increased to 150% and then 250%.
August 7, 2025

Germany’s 1Q Health Group acquires Beauty Production, expanding European CDMO platform

Germany-based Contract Development and Manufacturing Organisation (CDMO) 1Q Health Group, backed by European private equity firm Nord Holding, has acquired Beauty Production GmbH, a contract manufacturer specialising in liquid dietary supplements and cosmetics. HBI spoke with Holger Ebersberger, who is a private equity partner at McDermott Will & Schulte in Munich, to discuss his views on the acquisition, current deal activity in the CDMO and health manufacturing sectors across Germany and Europe, and the key factors driving investment in these areas.
August 7, 2025
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us